PUBLISHER: The Business Research Company | PRODUCT CODE: 2045532
PUBLISHER: The Business Research Company | PRODUCT CODE: 2045532
RO antiscalant is a specialty chemical used in reverse osmosis (RO) water treatment systems to prevent scale buildup on membrane surfaces. It inhibits the crystallization and deposition of sparingly soluble salts such as calcium carbonate, calcium sulfate, and silica, thereby preserving membrane efficiency and flow performance. By minimizing scaling and fouling, RO antiscalants extend membrane lifespan, reduce operational costs, and enhance overall water purification efficiency.
The main types of RO antiscalant include phosphorus antiscalants, synthetic polymeric antiscalants, and natural green antiscalants. Phosphorus antiscalants refer to chemical compounds used to prevent scale formation on reverse osmosis membranes by inhibiting crystallization of salts. These antiscalants are available in different formulations, including liquid antiscalants and powder or solid antiscalants. They are used across various applications, such as seawater desalination, brackish water treatment, municipal water treatment, industrial water treatment, wastewater treatment and reuse, food and beverage processing, pharmaceutical and healthcare water purification, power generation, and other applications, and serve multiple end-users, including industrial, power plants, petrochemicals, chemical manufacturing, electronics and semiconductors, mining, municipal, commercial, residential, and other end-users.
Tariffs on imported specialty chemicals and raw materials for RO antiscalants are impacting the market by raising production costs and supply chain complexities, particularly affecting segments such as synthetic polymeric and phosphorus-based antiscalants. Regions including North America, Europe, and Asia-Pacific that rely on chemical imports are most affected. While tariffs increase costs, they also encourage local production of antiscalants, promote domestic suppliers, and incentivize the development of cost-efficient and environmentally friendly formulations, creating new market opportunities.
The reverse osmosis (RO) antiscalant market research report is one of a series of new reports from The Business Research Company that provides reverse osmosis (RO) antiscalant market statistics, including reverse osmosis (RO) antiscalant industry global market size, regional shares, competitors with a reverse osmosis (RO) antiscalant market share, detailed reverse osmosis (RO) antiscalant market segments, market trends and opportunities, and any further data you may need to thrive in the reverse osmosis (RO) antiscalant industry. This reverse osmosis (RO) antiscalant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The reverse osmosis (RO) antiscalant market size has grown strongly in recent years. It will grow from $4.01 billion in 2025 to $4.22 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to increasing use of RO systems, rising scaling issues in water treatment, adoption of phosphorus-based antiscalants, growth of municipal and industrial water infrastructure, demand for higher membrane lifespan.
The reverse osmosis (RO) antiscalant market size is expected to see strong growth in the next few years. It will grow to $5.22 billion by 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to growing adoption of synthetic polymeric and natural green antiscalants, expansion of seawater desalination projects, increasing industrial water treatment applications, rising focus on environmental compliance, development of advanced antiscalant formulations for complex water chemistries. Major trends in the forecast period include increasing adoption of green and biodegradable antiscalants, rising demand for liquid antiscalant formulations, growing integration of ro antiscalants in industrial water treatment, expansion of antiscalant use in seawater desalination plants, rising focus on scale prevention in pharmaceutical and food & beverage water systems.
The expansion of the pharmaceutical and biotech sectors is expected to propel the growth of the RO antiscalant market going forward. The pharmaceutical and biotech sectors encompass companies engaged in drug discovery, development, manufacturing, and biologics production. The pharmaceutical and biotech sectors are expanding primarily due to rising R&D investments, as organizations intensify their efforts to develop innovative drugs and biologics, thereby contributing to overall sector advancement. RO antiscalants are utilized in these sectors to prevent scaling in reverse osmosis systems that generate ultra-pure water for formulation, equipment cleaning, and processing, thereby supporting consistent water quality, safeguarding membrane integrity, and maintaining operational efficiency. For instance, in October 2025, according to official UK government statistics, life sciences manufacturing turnover reached $61.57 billion (£46.5 billion) in 2023-2024, accounting for 32% of total sector turnover. Therefore, the expansion of the pharmaceutical and biotech sectors is driving the growth of the RO antiscalant market.
Companies operating in the RO antiscalant market are focusing on developing advanced solutions such as smart antiscalant dosing systems to enhance efficiency and reduce chemical and energy consumption. Smart antiscalant dosing systems utilize real-time data analytics and automated controls to adjust chemical dosing based on water quality and operational conditions, thereby minimizing waste and optimizing system performance. In 2025, Grundfos, a Denmark-based company, implemented its Smart Filtration Suite featuring the SmartRO algorithm at a desalination plant in Vadodara, India. The system autonomously determines optimal dosing levels through integrated data analytics, an antiscalant controller, and an optimization module operating in automated mode. This solution reduced energy consumption by 7% and chemical usage by 68%, while also lowering pump energy requirements, demonstrating significant improvements in operational efficiency.
In February 2025, Solenis, a US-based provider of specialty chemicals and water treatment solutions, acquired NCH Corporation for an undisclosed amount. With this acquisition, Solenis intends to broaden its global presence, enhance its technological capabilities, and diversify its portfolio across industrial and water treatment applications. NCH Corporation is a US-based company that provides reverse osmosis (RO) antiscalants through its water treatment division.
Major companies operating in the reverse osmosis (RO) antiscalant market are BASF SE, Dow Chemicals, Ecolab Inc., Veolia, SNF Floerger, Gradiant, DuPont, Kurita Water Industries Ltd., Univar Solutions LLC, Kemira Oyg, Genoasis, Genesys International Ltd., Avista Membrane Solutions, Solenis, Shandong IRO Water Treatment Co., Ltd., ACURO ORGANICS LIMITED, Jayem Engineers, GreenFission Chemicals Private Limited, Radik Chemicals, BioKrishi Technologies Pvt. Ltd., Candour Water Solutions'
Asia-Pacific was the largest region in the reverse osmosis (RO) antiscalant market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the reverse osmosis (RO) antiscalant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the reverse osmosis (RO) antiscalant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The reverse osmosis (RO) Antiscalant market consists of sales of organophosphonate antiscalants, polyacrylate antiscalants, sulfonated copolymer antiscalants, silica control antiscalants, sulfate scale inhibitors, carbonate scale inhibitors, liquid RO antiscalant solutions, and concentrated RO antiscalant formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Reverse Osmosis (RO) Antiscalant Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses reverse osmosis (ro) antiscalant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for reverse osmosis (ro) antiscalant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The reverse osmosis (ro) antiscalant market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.